High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.3M
$3,295,151
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Other
|
2026-02-04 | $26,040 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
10b5-1 Sell
|
2026-02-04 | $39,597 | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Other
|
2026-01-12 | $52,081 | M | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
10b5-1 Sell
|
2026-01-12 | $77,220 | S | Form 4 |
|
ADPT
M
Adaptive Biotechnologies Corp
PISKEL KYLE
• CFO
Equity Compensation
2025-11-28
$1,253,541Largex6
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Equity Compensation
|
2025-11-28 | $1,253,541Largex6 | M | Form 4 |
|
ADPT
S
Adaptive Biotechnologies Corp
PISKEL KYLE
• CFO
10b5-1 SellΔOwn -42.9%
2025-11-28
$3,174,990Large
|
||||||
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
10b5-1 SellΔOwn -42.9%
|
2025-11-28 | $3,174,990Large | S | Form 4 |
| ADPT |
Adaptive Biotechnologies Corp
|
CFO
Sell to Cover
|
2025-11-17 | $3,344 | S | Form 4 |